THBD and Disseminated intravascular coagulation: Several studies demonstrated that anticoagulant treatment, including the administration of recombinant human soluble thrombomodulin (rTM), could improve the outcomes of patients with gastroenterological sepsis-induced disseminated intravascular coagulation (DIC).